Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells.
Wu
Qiong
Q
Department of Medical Oncology, Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
Qin
Shu-Kui
SK
Teng
Feng-Meng
FM
Chen
Chang-Jie
CJ
Wang
Rui
R
D016203:CDC2 Protein Kinase / Q000096:biosynthesis / Q000235:genetics; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D018929:Cell Culture Techniques; D002453:Cell Cycle / Q000187:drug effects; D048708:Cell Growth Processes / Q000187:drug effects; D045744:Cell Line, Tumor; D019926:Cyclin B / Q000096:biosynthesis / Q000235:genetics; D051358:Cyclin-Dependent Kinase 4 / Q000096:biosynthesis / Q000235:genetics; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000096:biosynthesis / Q000235:genetics; D050760:Cyclin-Dependent Kinase Inhibitor p27 / Q000096:biosynthesis / Q000235:genetics; D003503:Cyclobutanes / Q000494:pharmacology*; D015536:Down-Regulation / Q000187:drug effects; D050684:E2F Transcription Factors / Q000096:biosynthesis / Q000235:genetics; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D009944:Organoplatinum Compounds / Q000494:pharmacology*; D016160:Retinoblastoma Protein / Q000096:biosynthesis / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis / Q000235:genetics; D015854:Up-Regulation / Q000187:drug effects; D020687:cdc25 Phosphatases / Q000096:biosynthesis / Q000235:genetics
C493956:CDKN1A protein, human; D019926:Cyclin B; D050759:Cyclin-Dependent Kinase Inhibitor p21; D003503:Cyclobutanes; D050684:E2F Transcription Factors; D009944:Organoplatinum Compounds; D016160:Retinoblastoma Protein; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D050760:Cyclin-Dependent Kinase Inhibitor p27; D016203:CDC2 Protein Kinase; C495900:CDK4 protein, human; D051358:Cyclin-Dependent Kinase 4; C517009:CDC25C protein, human; D020687:cdc25 Phosphatases; C066228:lobaplatin